The U.S. Food and Drug Administration today is requiring safety labeling changes for a class of antibiotics called fluoroquinolones to strengthen the warnings about the risks of mental health side effects and serious blood sugar disturbances, and make these warnings more consistent across the labeling for all fluoroquinolones taken by mouth or given by injection. […]
Αγαπητοί συνάδελφοι, Έχω τη μεγάλη χαρά να σας γνωστοποιήσω ότι η Ευρωπαϊκή Ρευματολογική Εταιρεία συνέταξε για πρώτη φορά Συστάσεις για τη θεραπεία του Αντιφωσφολιπιδικού Συνδρόμου, όπου Επικεφαλής της Ομάδας Εργασίας και πρώτη Συγγραφέας των παρακάτω σχετικών άρθρων ήταν η κα. Μαρία Τεκτονίδου, Αναπληρώτρια Καθηγήτρια της Α΄ Προπαιδευτικής Παθολογικής Κλινικής του Πανεπιστημίου Αθηνών. Με εκτίμηση, Καθηγητής […]
Abstract The objective was to develop evidence-based recommendations for the management of antiphospholipid syndrome (APS) in adults. Based on evidence from a systematic literature review and expert opinion, overarching principles and recommendations were formulated and voted. High-risk antiphospholipid antibody (aPL) profile is associated with greater risk for thrombotic and obstetric APS. Risk modification includes screening […]
ABSTRACT Objective To perform a systematic literature review (SLR) informing the European Lmmendations for the management of antiphospholipid syndrome (APS) in adults. Methods A SLR through January 2018 was performed. Research questions were constructed using the Patient, Intervention, Comparator, Outcome (PICO) format. We included data from articles that reported on each relevant intervention. Summary effect […]
Πρόσφατα σχόλια